Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that affects the Veterans and the general population. Currently, there is no effective treatment and most patients die within 2 years after disease onset. One important neuropathology hallmark of ALS is the accumulation of misfolded proteins within the affected neurons, which progressively and irreversibly activate endoplasmic reticulum (ER) stress cell death mechanisms. Indeed, there is mounting evidence that ER stress is an important mechanism driving neurotoxicity in ALS. However, it is unclear how ER stress leads to apoptosis in ALS or whether this highly conserved mechanism can be harnessed to develop therapeutic targets that can improve the ability of neurons to reset the homeostasis of unfolded protein response (UPR), mitigate the disease progression, and prolong the survival in ALS patients. This new RR&D Merit Review proposal will develop small molecule chemicals that block ER stress-induced neurodegeneration in pre-clinical models of ALS. Our unpublished data support an important role of stress-activated protein kinase HIPK2 (homeodomain interacting protein kinase 2) in activating ER stress induced by chemical agents and in mouse model of neurodegeneration caused by mutant SOD1G93A protein. Interestingly, similar HIPK2 activation has also been identified in tissues from patients with familial and sporadic ALS. Together, these results provide proof-of-principle evidence that blocking HIPK2 can protect motor neurons neurodegeneration caused by misfolded mutant proteins in familial and sporadic ALS. If successful, our research will have profound impacts on the diagnosis, treatment, and rehabilitation of Veterans who suffer from ALS.

Public Health Relevance

Amyotrophic lateral sclerosis (ALS) is a fatal disease caused by the selective degeneration of motor neurons in the central nervous system. Veterans with ALS suffer from severe muscle wasting/weakness and eventually die from respiratory failure. One consistent neuropathological feature in ALS is the presence of misfolded proteins in the spinal motor neurons, which activates irreversible cell death mechanism leading to neurodegeneration. In this application, we propose an array of interdisciplinary approaches to investigate if blocking the HIPK2 signaling pathway using pharmacological and genetic technologies will mitigate cell death in the several preclinical models of ALS. Results from this project will provide new insights into the ER stress- dependent cell death of spinal motor neurons, and new therapeutic targets to treating Veterans with ALS.

Agency
National Institute of Health (NIH)
Institute
Veterans Affairs (VA)
Type
Non-HHS Research Projects (I01)
Project #
1I01RX002133-01
Application #
9086083
Study Section
Blank (RRD6)
Project Start
2016-04-01
Project End
2020-03-31
Budget Start
2016-04-01
Budget End
2017-03-31
Support Year
1
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Veterans Affairs Medical Center San Francisco
Department
Type
DUNS #
078763885
City
San Francisco
State
CA
Country
United States
Zip Code
94121
Cahill, Michelle K; Huang, Eric J (2017) Testing the Amyloid Hypothesis with a Humanized AD Mouse Model. Neuron 93:987-989
Lee, Sebum; Huang, Eric J (2017) Modeling ALS and FTD with iPSC-derived neurons. Brain Res 1656:88-97
Ward, Michael E; Chen, Robert; Huang, Hsin-Yi et al. (2017) Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis. Sci Transl Med 9:
Lombardi, Laura M; Zaghlula, Manar; Sztainberg, Yehezkel et al. (2017) An RNA interference screen identifies druggable regulators of MeCP2 stability. Sci Transl Med 9:
Kao, Aimee W; McKay, Andrew; Singh, Param Priya et al. (2017) Progranulin, lysosomal regulation and neurodegenerative disease. Nat Rev Neurosci 18:325-333
Le Pichon, Claire E; Meilandt, William J; Dominguez, Sara et al. (2017) Loss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative disease. Sci Transl Med 9:
Celona, Barbara; Dollen, John von; Vatsavayai, Sarat C et al. (2017) Suppression of C9orf72 RNA repeat-induced neurotoxicity by the ALS-associated RNA-binding protein Zfp106. Elife 6:
Lui, Hansen; Zhang, Jiasheng; Makinson, Stefanie R et al. (2016) Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation. Cell 165:921-35
Luo, Sarah X; Timbang, Leah; Kim, Jae-Ick et al. (2016) TGF-? Signaling in Dopaminergic Neurons Regulates Dendritic Growth, Excitatory-Inhibitory Synaptic Balance, and Reversal Learning. Cell Rep 17:3233-3245
Shang, Yulei; Huang, Eric J (2016) Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis. Brain Res 1647:65-78

Showing the most recent 10 out of 11 publications